TrialThe Journal of clinical endocrinology and metabolism2025

Safety and Efficacy of Moderate-dose Denosumab in Fibrous Dysplasia: Observational Results From a Phase 2 Clinical Trial.

Vivian Szymczuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.